Skip to content

News - Page 10

22nd North American ISSX Meeting - Montreal, Canada
11th July, 2018

22nd North American ISSX Meeting – Montréal, Canada (15th-19th July)

The meeting brings together individuals who are working on drug/xenobiotic research across a diverse range of fields such as clinical pharmacology and therapeutics, toxicology, oncology, endocrinology, physiology, biochemistry, medicinal…

Read update
Dr Mike Nicholds and Professor Lyle Armstrong
4th July, 2018

NB secures £2M investment from NVM Private Equity & Northstar Ventures to accelerate hiPSC growth

Founded on the technology of Prof Lyle Armstrong and Prof Majlinda Lako from Newcastle University, the company is at the forefront of the production and differentiation of human induced…

Read update
BBC interview
22nd June, 2018

How the NHS Changed Our World: Tyneside’s Genetic Pioneers on BBC 1 (North East & Cumbria)

To watch the full video click here.

Read update
Very close up image of an eye
20th June, 2018

Review article – Cellular regeneration strategies for macular degeneration: past, present & future

Abstract Despite considerable effort and significant therapeutic advances, age-related macular degeneration (AMD) remains the commonest cause of blindness in the developed world. Progressive late-stage AMD with outer retinal degeneration currently…

Read update
World Preclinical Congress
15th June, 2018

17th Annual World Preclinical Congress – Boston, MA (18th-21st June)

Dr Brown is the developer of the aProximateTM assay for measuring kidney transporter and nephrotoxicity licensed exclusively to Newcells Biotech. The World Preclinical Congress is a key networking event focusing on…

Read update
FMS Post-Doc Symposium 2018 – Newcastle University (15th June 2018)
13th June, 2018

FMS Post-Doc Symposium 2018 – Newcastle University (15th June 2018)

Dr Chichagova will be talking about Retinitis Pigmentosa, one of the most common forms of inherited blindness affecting over 1 million people worldwide.With no effective treatment available for Retinitis…

Read update
A member of staff at Newcells winning a prize
23rd May, 2018

Dr Chichagova awarded best In Vitro Toxicology Society poster

Using statistical modelling, Dr Chichagova was able to improve the differentiation outcome of human induced pluripotent stem cells to retinal organoids, which were subsequently successfully tested with a toxicologically relevant test compound.   As…

Read update
An overview of Gateshead
13th April, 2018

British Toxicological Society Annual Congress 2018 – Hilton Gateshead (16th-18th April)

Hilton Gateshead – 16th-18th April https://www.thebts.org/bts-annual-congress-2018/ The Newcells Biotech team will be attending the British Toxicological Society Annual Congress 2018 that is taking place in Gateshead on 16th-18th April.  Newcells Biotech staff…

Read update
Newcells Biotech to develop 3D retinal organoids using hiPSC derived skin cells
11th January, 2018

NB to develop 3D retinal organoids using hiPSC derived skin cells

Newcells Biotech in partnership with Newcastle University has been awarded further funding from the NC3R CRACK IT project to create 3D retinal organoids that more closely recapitulate the structure…

Read update

Get our latest updates straight to your inbox

Book a Call